Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Soligenix, Inc.

http://www.soligenix.com/

Latest From Soligenix, Inc.

HBW Market Executive Decisions: Unilever’s Next CEO, CRN Staff, GOED Board, PLZ CEO

Unilever names Schumacher as Jope’s successor at CEO; specialty aerosol, liquid products firm PLZ appoints CEO; GOED seats 2023 board officers; and CRN adds and promotes staff members.

Executive Changes Consumer

Keeping Track: US FDA Oncology Approvals For Ferring’s Gene Therapy Adstiladrin And Mirati’s Targeted Therapy Krazati

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker

US FDA Performance Tracker Approvals

FTC Considers Adding ‘Organic’ and ‘Sustainable’ Guidance In Environmental Claims Update

FTC asks for comments on whether it should consider issuing guidance on “organic” and “sustainable” claims in an update to its Green Guides. Commission will collect public comments for 60 days beginning mid-January for first update to guides in 10 years.

Consumer Guidance Documents

Asia Deal Watch: Eisai Advances Portfolio Focus With Divestiture Of Two Products To DKSH

Plus deals involving Dong-A/Polifarma, Intas/Syna, Kissei/Synmosa, Ono/Memo, Takeda/Shionogi, Fosun/Lilly and JW Therapeutics/2seventy bio.

Deal Watch Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Vaccines
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Biological Therapeutics, Inc.
    • DOR BioPharma, Inc.
    • Endorex Corporation
    • Enteron Pharmaceuticals
    • Immunotherapeutics Inc.
UsernamePublicRestriction

Register